🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Missing my pups while away from home. Thank you #AANAM for getting me my puppy fill ❤️ 🐶

Tough one today!!! Neurdle 7 3/6 ⬛⬛⬛🟩⬛ 🟨🟨⬛🟩⬛ 🟩🟩🟩🟩🟩 #AANAM #Neurdle American Academy of Neurology

#ICYMI: We're offering a free, self-paced #AdvancedPracticeProvider #Neurology Bootcamp! The virtual course is available online through 2026 & covers various neurological conditions, neuroanatomy, & more. Get started here: bar.rw/appbootcamp

It really was catching up with old friends (but yes finally in-person) while also making so new!! Women Neurologists Group is such a special group of the most inspiring women❤️ #AANAM

Guess she found a 🎫 during the plenary 😉

Thank you organizing such an amazing Women Neurologists Group night at #AANAM American Academy of Neurology

I know!!!!

Such an amazing night!

Come learn how headache neurologists currently approach status migrainosus and participate in the survey yourself! Happening soon in neighborhood 12! Come visit me to chat! #AANAM BarrowNeurological

Check out my poster at #AANAM today!   Status migrainosus is a debilitating #migraine complication with intense symptoms lasting over 72h. Our survey entailed phone interviews with 33 headache specialists from across the U.S.

DHE via IV was viewed as a favorable treatment for status migrainosus, though it was underutilized and often only as a last resort due to accessibility issues.   INP104 allows patients to administer DHE at home with IV-like efficacy.   Abstract: aan.com/MSA/Public/Eve…

Power team this morning!! ❤️ #AANAM

Finish line is here. What a great week at #AANAM 2023 in Boston! Thanks for all the learning, networking and inspiration. And my hat!

The Barrow Neuromuscular Disorders team, led by Shafeeq Ladha, played a key role in research trials that led to the approval of #tofersen. The new drug targets a genetic form of #ALS and is a great example of personalized medicine for ALS. barrowneuro.org/about/news-and…

Look at all of us!! What an inspiring group of powerful women!! ❤️

The AHS and @NINDSnews are soliciting input from all interested stakeholders, including researchers, health care providers, individuals with #headache disorders, patient advocates and health #advocacy organizations, scientific or professional organizations, federal agencies, and

A population-based, case-control study co-authored by Barrow #Neurology Chairman & Senior VP Dr. Brad Racette, MD associated a common gout medication with a reduced risk of #Alzheimers, #Parkinsons, & #ALS. Press release: bar.rw/42GY4k6 #ALSMonth #ALSAwarenessMonth

A population-based, case-control study from my lab associated the gout medication allopurinol with a lower risk of #Alzheimers, #Parkinsons, & #ALS. Our findings were published yesterday in @PLOSOne. Learn more: bar.rw/allopurinol. #ALSMonth